世界の整形外科粘弾性サプリメント市場予測（～2028年）：ヒアルロン酸ナトリウム注射剤、医療用キトサン

• 英文タイトル：Global Orthopaedic Viscoelastic Supplement Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8243 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

整形外科粘弾性サプリメント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の整形外科粘弾性サプリメントの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 整形外科粘弾性サプリメント市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ヒアルロン酸ナトリウム注射剤、医療用キトサン 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の整形外科粘弾性サプリメント市場の主要な市場プレーヤーは以下のとおりです。 ・Corneal (Allergan)、Galdermal (Q-Med)、LG Life Science、Bohus BioTech、IMEIK、Bloomage Freda、Shanghai Haohai Biological Technology 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、整形外科粘弾性サプリメント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な整形外科粘弾性サプリメントメーカーの企業概要、2019年～2022年までの整形外科粘弾性サプリメントの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な整形外科粘弾性サプリメントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別整形外科粘弾性サプリメントの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの整形外科粘弾性サプリメントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での整形外科粘弾性サプリメント市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および整形外科粘弾性サプリメントの産業チェーンを掲載しています。 ・第13、14、15章では、整形外科粘弾性サプリメントの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Corneal (Allergan)、Galdermal (Q-Med)、LG Life Science、Bohus BioTech、IMEIK、Bloomage Freda、Shanghai Haohai Biological Technology ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ヒアルロン酸ナトリウム注射剤、医療用キトサン ・用途別分析2017年-2028年：病院、クリニック、その他 ・整形外科粘弾性サプリメントの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・整形外科粘弾性サプリメントのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・整形外科粘弾性サプリメントのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・整形外科粘弾性サプリメントの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・整形外科粘弾性サプリメントの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Orthopaedic Viscoelastic Supplement market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Orthopaedic Viscoelastic Supplement market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Orthopaedic Viscoelastic Supplement global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sodium Hyaluronate Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Orthopaedic Viscoelastic Supplement include Corneal (Allergan), Galdermal (Q-Med), LG Life Science, Bohus BioTech, and IMEIK, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Orthopaedic Viscoelastic Supplement market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sodium Hyaluronate Injection
Medical Chitosan
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Orthopaedic Viscoelastic Supplement market are listed below:
Corneal (Allergan)
Galdermal (Q-Med)
LG Life Science
Bohus BioTech
IMEIK
Bloomage Freda
Shanghai Haohai Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orthopaedic Viscoelastic Supplement product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orthopaedic Viscoelastic Supplement, with price, sales, revenue and global market share of Orthopaedic Viscoelastic Supplement from 2019 to 2022.
Chapter 3, the Orthopaedic Viscoelastic Supplement competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orthopaedic Viscoelastic Supplement breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Orthopaedic Viscoelastic Supplement market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orthopaedic Viscoelastic Supplement.
Chapter 13, 14, and 15, to describe Orthopaedic Viscoelastic Supplement sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Orthopaedic Viscoelastic Supplement Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orthopaedic Viscoelastic Supplement Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Sodium Hyaluronate Injection
1.2.3 Medical Chitosan
1.3 Market Analysis by Application
1.3.1 Overview: Global Orthopaedic Viscoelastic Supplement Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Orthopaedic Viscoelastic Supplement Market Size & Forecast
1.4.1 Global Orthopaedic Viscoelastic Supplement Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Orthopaedic Viscoelastic Supplement Sales in Volume (2017-2028)
1.4.3 Global Orthopaedic Viscoelastic Supplement Price (2017-2028)
1.5 Global Orthopaedic Viscoelastic Supplement Production Capacity Analysis
1.5.1 Global Orthopaedic Viscoelastic Supplement Total Production Capacity (2017-2028)
1.5.2 Global Orthopaedic Viscoelastic Supplement Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Orthopaedic Viscoelastic Supplement Market Drivers
1.6.2 Orthopaedic Viscoelastic Supplement Market Restraints
1.6.3 Orthopaedic Viscoelastic Supplement Trends Analysis
2 Manufacturers Profiles
2.1 Corneal (Allergan)
2.1.1 Corneal (Allergan) Details
2.1.2 Corneal (Allergan) Major Business
2.1.3 Corneal (Allergan) Orthopaedic Viscoelastic Supplement Product and Services
2.1.4 Corneal (Allergan) Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Galdermal (Q-Med)
2.2.1 Galdermal (Q-Med) Details
2.2.2 Galdermal (Q-Med) Major Business
2.2.3 Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Product and Services
2.2.4 Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 LG Life Science
2.3.1 LG Life Science Details
2.3.2 LG Life Science Major Business
2.3.3 LG Life Science Orthopaedic Viscoelastic Supplement Product and Services
2.3.4 LG Life Science Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bohus BioTech
2.4.1 Bohus BioTech Details
2.4.2 Bohus BioTech Major Business
2.4.3 Bohus BioTech Orthopaedic Viscoelastic Supplement Product and Services
2.4.4 Bohus BioTech Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 IMEIK
2.5.1 IMEIK Details
2.5.2 IMEIK Major Business
2.5.3 IMEIK Orthopaedic Viscoelastic Supplement Product and Services
2.5.4 IMEIK Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bloomage Freda
2.6.1 Bloomage Freda Details
2.6.2 Bloomage Freda Major Business
2.6.3 Bloomage Freda Orthopaedic Viscoelastic Supplement Product and Services
2.6.4 Bloomage Freda Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Haohai Biological Technology
2.7.1 Shanghai Haohai Biological Technology Details
2.7.2 Shanghai Haohai Biological Technology Major Business
2.7.3 Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Product and Services
2.7.4 Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Orthopaedic Viscoelastic Supplement Breakdown Data by Manufacturer
3.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Orthopaedic Viscoelastic Supplement Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Orthopaedic Viscoelastic Supplement
3.4 Market Concentration Rate
3.4.1 Top 3 Orthopaedic Viscoelastic Supplement Manufacturer Market Share in 2021
3.4.2 Top 6 Orthopaedic Viscoelastic Supplement Manufacturer Market Share in 2021
3.5 Global Orthopaedic Viscoelastic Supplement Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Orthopaedic Viscoelastic Supplement Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Orthopaedic Viscoelastic Supplement Market Size by Region
4.1.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Region (2017-2028)
4.1.2 Global Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2028)
4.2 North America Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.3 Europe Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.4 Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.5 South America Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.6 Middle East and Africa Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Type (2017-2028)
5.2 Global Orthopaedic Viscoelastic Supplement Revenue by Type (2017-2028)
5.3 Global Orthopaedic Viscoelastic Supplement Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Application (2017-2028)
6.2 Global Orthopaedic Viscoelastic Supplement Revenue by Application (2017-2028)
6.3 Global Orthopaedic Viscoelastic Supplement Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
7.2 North America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
7.3 North America Orthopaedic Viscoelastic Supplement Market Size by Country
7.3.1 North America Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
7.3.2 North America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
8.2 Europe Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
8.3 Europe Orthopaedic Viscoelastic Supplement Market Size by Country
8.3.1 Europe Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
8.3.2 Europe Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
9.2 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
9.3 Asia-Pacific Orthopaedic Viscoelastic Supplement Market Size by Region
9.3.1 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
10.2 South America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
10.3 South America Orthopaedic Viscoelastic Supplement Market Size by Country
10.3.1 South America Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
10.3.2 South America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
11.2 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
11.3 Middle East & Africa Orthopaedic Viscoelastic Supplement Market Size by Country
11.3.1 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Orthopaedic Viscoelastic Supplement and Key Manufacturers
12.2 Manufacturing Costs Percentage of Orthopaedic Viscoelastic Supplement
12.3 Orthopaedic Viscoelastic Supplement Production Process
12.4 Orthopaedic Viscoelastic Supplement Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Orthopaedic Viscoelastic Supplement Typical Distributors
13.3 Orthopaedic Viscoelastic Supplement Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---